JP2006523185A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006523185A5 JP2006523185A5 JP2006503571A JP2006503571A JP2006523185A5 JP 2006523185 A5 JP2006523185 A5 JP 2006523185A5 JP 2006503571 A JP2006503571 A JP 2006503571A JP 2006503571 A JP2006503571 A JP 2006503571A JP 2006523185 A5 JP2006523185 A5 JP 2006523185A5
- Authority
- JP
- Japan
- Prior art keywords
- hybrid antigen
- tumor
- medicament
- heat shock
- shock protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44714203P | 2003-02-13 | 2003-02-13 | |
| US46246903P | 2003-04-11 | 2003-04-11 | |
| US46374603P | 2003-04-18 | 2003-04-18 | |
| US50341703P | 2003-09-16 | 2003-09-16 | |
| US10/776,521 US7420037B2 (en) | 2003-02-13 | 2004-02-12 | Heat shock protein-based vaccines and immunotherapies |
| PCT/US2004/004340 WO2004071457A2 (en) | 2003-02-13 | 2004-02-13 | Improved heat shock protein-based vaccines and immunotherapies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006523185A JP2006523185A (ja) | 2006-10-12 |
| JP2006523185A5 true JP2006523185A5 (https=) | 2007-05-10 |
Family
ID=32873068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006503571A Pending JP2006523185A (ja) | 2003-02-13 | 2004-02-13 | 改良された熱ショックタンパク質に基づくワクチンおよび免疫療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7420037B2 (https=) |
| EP (1) | EP1622563A4 (https=) |
| JP (1) | JP2006523185A (https=) |
| AU (1) | AU2004212003B2 (https=) |
| CA (1) | CA2520591A1 (https=) |
| WO (1) | WO2004071457A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6761892B1 (en) * | 1995-08-18 | 2004-07-13 | Sloan-Kettering Institute For Cancer Research | Heat shock protein-based vaccines and immunotherapies |
| US7309491B2 (en) * | 2003-04-11 | 2007-12-18 | Antigenics Inc. | Heat shock protein-based vaccines and immunotherapies |
| KR20050121721A (ko) * | 2003-04-11 | 2005-12-27 | 안티제닉스 아이엔씨 | 개량된 열 충격 단백질 기초 백신 및 면역치료법 |
| US7485312B2 (en) * | 2003-06-20 | 2009-02-03 | Dade Behring Marburg Gmbh | Surface protein (HBsAg) variant of the hepatitis B virus |
| JP2007505147A (ja) * | 2003-09-12 | 2007-03-08 | アンティジェニクス インコーポレーテッド | 単純ヘルペスウイルス感染の治療および予防用ワクチン |
| US20060018911A1 (en) * | 2004-01-12 | 2006-01-26 | Dana Ault-Riche | Design of therapeutics and therapeutics |
| KR20070122563A (ko) | 2005-04-19 | 2007-12-31 | 일라이 릴리 앤드 캄파니 | 질병에의 면역학적 개입을 위한 1가 및 다가 합성 다당류항원 |
| CN103328496A (zh) | 2010-10-25 | 2013-09-25 | 中央研究院 | 癌靶向肽及其于癌症治疗与诊断的应用 |
| WO2013011095A1 (en) * | 2011-07-21 | 2013-01-24 | Biotech Tools S.A. | Dosage of dnak |
| SG10201912485PA (en) * | 2015-05-13 | 2020-02-27 | Agenus Inc | Vaccines for treatment and prevention of cancer |
| WO2018187515A1 (en) * | 2017-04-04 | 2018-10-11 | Avidea Technologies, Inc. | Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response |
| MA52363A (fr) * | 2018-04-26 | 2021-03-03 | Agenus Inc | Compositions peptidiques de liaison à une protéine de choc thermique (hsp) et leurs méthodes d'utilisation |
| CN115397519A (zh) * | 2019-07-24 | 2022-11-25 | 艾吉纳斯公司 | 抗原性多肽及其使用方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8727030D0 (en) | 1987-11-18 | 1987-12-23 | Imp Cancer Res Tech | Production of monoclonal antibodies |
| WO1994029459A1 (en) | 1993-06-04 | 1994-12-22 | Whitehead Institute For Biomedical Research | Stress proteins and uses therefor |
| US5498538A (en) | 1990-02-15 | 1996-03-12 | The University Of North Carolina At Chapel Hill | Totally synthetic affinity reagents |
| US5348945A (en) | 1990-04-06 | 1994-09-20 | Wake Forest University | Method of treatment with hsp70 |
| IL99821A (en) | 1991-10-22 | 1996-07-23 | Yeda Res & Dev | Antitumor vaccines comprising cells transfected with a gene encoding human il-6 |
| GB9202219D0 (en) | 1992-02-03 | 1992-03-18 | Connaught Lab | A synthetic heamophilus influenzae conjugate vaccine |
| IT1262896B (it) | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
| GB9223816D0 (en) | 1992-11-13 | 1993-01-06 | Medical Res Council | Heat shock proteins and the treatment of tumours |
| US5997873A (en) | 1994-01-13 | 1999-12-07 | Mount Sinai School Of Medicine Of The City University Of New York | Method of preparation of heat shock protein 70-peptide complexes |
| US5750119A (en) | 1994-01-13 | 1998-05-12 | Mount Sinai School Of Medicine Of The City University Of New York | Immunotherapeutic stress protein-peptide complexes against cancer |
| US5961979A (en) | 1994-03-16 | 1999-10-05 | Mount Sinai School Of Medicine Of The City University Of New York | Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| US5541109A (en) | 1994-04-19 | 1996-07-30 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Expression cloning of c-src SH3-domain binding proteins |
| WO1997006821A1 (en) | 1995-08-18 | 1997-02-27 | Sloan-Kettering Institute For Cancer Research | Heat shock protein-based vaccines and immunotherapies |
| US5985270A (en) | 1995-09-13 | 1999-11-16 | Fordham University | Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes |
| US5935576A (en) | 1995-09-13 | 1999-08-10 | Fordham University | Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens |
| WO1997010000A1 (en) | 1995-09-13 | 1997-03-20 | Fordham University | Therapeutic and prophylactic methods using heat shock proteins |
| US5837251A (en) | 1995-09-13 | 1998-11-17 | Fordham University | Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases |
| US6127393A (en) | 1995-12-29 | 2000-10-03 | Novactyl, Inc. | Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method |
| WO1997026910A2 (de) | 1996-01-27 | 1997-07-31 | Max-Delbrück-Centrum für Molekulare Medizin | Tumorimpfstoff für die immuntherapie von malignen tumoren |
| JP4484969B2 (ja) | 1996-11-26 | 2010-06-16 | ヌベンタ バイオファーマスティカル コーポレイション | ストレスタンパク質を含む組成物を使用する免疫応答 |
| US6017540A (en) | 1997-02-07 | 2000-01-25 | Fordham University | Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
| CA2282426A1 (en) | 1997-02-18 | 1998-08-20 | The Whitehead Institute For Biomedical Research | Use of heat shock proteins to deliver moieties into cells |
| US5962262A (en) | 1997-07-25 | 1999-10-05 | Incyte Pharmaceuticals, Inc. | Human heat shock 27 like protein |
| EP1027070A4 (en) | 1997-10-31 | 2004-08-18 | Sloan Kettering Institutefor C | CONJUGATES FROM HEAT SHOCK PROTEIN-BINDING PEPTIDES |
| JP4768122B2 (ja) | 1998-02-20 | 2011-09-07 | ユニバーシティー オブ マイアミ | 改変型熱ショックタンパク質−抗原性ペプチド複合体 |
| US6258782B1 (en) | 1998-05-20 | 2001-07-10 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
| WO2001078772A1 (en) | 2000-04-17 | 2001-10-25 | Mojave Therapeutics Inc. | Heat shock protein-based antiviral vaccines |
| US20040043419A1 (en) | 2001-04-17 | 2004-03-04 | Rothman James E. | Javelinization of protein antigens to heat shock proteins |
| US20040071656A1 (en) | 2001-12-26 | 2004-04-15 | Felix Wieland | Modulation of heat-shock-protein-based immunotherapies |
| US7309491B2 (en) | 2003-04-11 | 2007-12-18 | Antigenics Inc. | Heat shock protein-based vaccines and immunotherapies |
-
2004
- 2004-02-12 US US10/776,521 patent/US7420037B2/en not_active Expired - Lifetime
- 2004-02-13 AU AU2004212003A patent/AU2004212003B2/en not_active Ceased
- 2004-02-13 CA CA002520591A patent/CA2520591A1/en not_active Abandoned
- 2004-02-13 JP JP2006503571A patent/JP2006523185A/ja active Pending
- 2004-02-13 WO PCT/US2004/004340 patent/WO2004071457A2/en not_active Ceased
- 2004-02-13 EP EP04711217A patent/EP1622563A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006523185A5 (https=) | ||
| ES2676630T3 (es) | Control inmunogénico de tumores y células tumorales | |
| JP2012511322A5 (https=) | ||
| JP2010516290A5 (https=) | ||
| JP2008535800A5 (https=) | ||
| JP2015509707A5 (https=) | ||
| CN104918637A (zh) | 用作诱发抗原特异性t细胞反应的免疫原性增强剂的融合蛋白 | |
| FI2970398T3 (fi) | Rsv f -prefuusioproteiineja ja niiden käyttö | |
| JP2011521662A5 (https=) | ||
| JP2018509935A5 (https=) | ||
| JP2008530245A5 (https=) | ||
| JP2012500006A5 (https=) | ||
| JP2009537143A5 (https=) | ||
| HRP20190799T1 (hr) | Imunocitokini na bazi il-15 i sushi domene il-15r alfa | |
| JP2012526839A5 (https=) | ||
| WO2003090686A3 (en) | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality | |
| JP2009515831A5 (https=) | ||
| AU2015204503A1 (en) | Novel vaccines against HPV and HPV-related diseases | |
| JP2016502515A5 (https=) | ||
| CN111565746A (zh) | 用于预防和治疗多种黄病毒的mhc i类相关肽 | |
| JP2010501594A5 (https=) | ||
| JP2009520758A5 (https=) | ||
| JP2019531293A5 (https=) | ||
| JP2015533376A5 (https=) | ||
| JP2012504602A5 (https=) |